Status:
TERMINATED
Acute Effects of the Prostaglandin (Alprostadil) on Cerebral and Pulmonary Flow
Lead Sponsor:
The Hospital for Sick Children
Conditions:
Congenital Heart Disease
Eligibility:
All Genders
1-6 years
Phase:
PHASE1
Brief Summary
The second stage operation towards single ventricle palliation is 'bidirectional cavopulmonary connection' (BCPC). The superior vena cava is connected to the pulmonary artery, diverting 'blue' blood f...
Eligibility Criteria
Inclusion
- • BCPC patients at time of routine pre-Fontan assessment: Cardiac catheterization and cardiac magnetic resonance imaging (CMR)
- • Patients between the ages of 1 and 6 years old.
Exclusion
- Patients who are hypersensitive to this product or to any ingredient in its formulation.
- Patients with seizure disorders or coagulopathies.
- Patients with abnormal kidney function.
Key Trial Info
Start Date :
July 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 9 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04054115
Start Date
July 23 2019
End Date
November 9 2022
Last Update
February 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Sick Children
Toronto, Ontario, Canada, L4K4x6